发明名称 SUBSTITUED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
摘要 The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.;
申请公布号 US2015246902(A1) 申请公布日期 2015.09.03
申请号 US201214343462 申请日期 2012.08.16
申请人 McComas Casey C.;Liverton Nigel J.;Habermann Joerg;Koch Uwe;Narjes Frank;Li Peng;Peng Xuanjia;Soll Richard;Wu Hao;Palani Anandan;Dai Xing;Liu Hong;He Shuwen;Dang Qun 发明人 McComas Casey C.;Liverton Nigel J.;Habermann Joerg;Koch Uwe;Narjes Frank;Li Peng;Peng Xuanjia;Soll Richard;Wu Hao;Palani Anandan;Dai Xing;Liu Hong;He Shuwen;Dang Qun
分类号 C07D405/04;C07D473/00;A61K31/52;A61K45/06;A61K31/437;C07D487/04;A61K31/4985;A61K31/5025;A61K31/4184;C07D471/04 主分类号 C07D405/04
代理机构 代理人
主权项 1. A compound having the formula:or a pharmaceutically acceptable salt thereof, wherein: A is:wherein A can be joined to the benzofuran moiety of formula (I) via any of group A's ring carbon atoms; L is N or CH; M is N or CH; Q is —CH(R4b); U is —N(R5)—, O, S or —C(R4b)2—; V is —N— or —C(R4a)—; W is —N— or —C(R4)—, or the group —W═V—U— is —NH—C(O)—N(R5)— one of Y1 and Y2 is —N— or —C(R10)—, and the other of Y1 and Y2 is a carbon atom and represents the point of attachment of the benzofuran moiety depicted in formula (I); X and Z are each independently —N— or —C(R10)—; R1 represents up to 4 optional ring substituents, which can be the same or different, and are independently selected from halo, C1-C6 alkyl, C1-C6 haloalkyl, phenyl, 3 to 7-membered monocyclic cycloalkyl, —O—(C1-C6 alkyl), —O—(C1-C6 haloalkyl) and —CN; R2 is —C(O)N(R6)(R7); R3 is 5 or 6-membered heterocycloalkyl or —N(R8)—S(O)n—R9, wherein said 5 or 6-membered heterocycloalkyl can optionally have one of its ring carbon atoms replaced with a carbonyl group; R4 is selected from H, halo, C1-C6 alkyl, C1-C6 haloalkyl, —O—(C1-C6 alkyl), —O—(C1-C6 haloalkyl), C1-C6 hydroxyalkyl, —C(O)O—(C1-C6 alkyl), —(C1-C6 alkylene)r-aryl, —(C1-C6 alkylene)r-(3 to 7-membered monocyclic cycloalkyl), —(C1-C6 alkylene)n-(4 to 7-membered monocyclic heterocycloalkyl), —(C1-C6 alkylene)n-(5 or 6-membered monocyclic heteroaryl) and —(C1-C6 alkylene)r-(9 or 10-membered bicyclic heteroaryl), wherein said aryl group, said 3 to 7-membered monocyclic cycloalkyl group, said 4 to 7-membered monocyclic heterocycloalkyl group, said 5 or 6-membered monocyclic heteroaryl group and said 9 or 10-membered bicyclic heteroaryl group can be optionally substituted with up to 3 groups, which can be the same or different, and are selected from halo, C1-C6 alkyl, C1-C6 haloalkyl, phenyl, 3 to 7-membered monocyclic cycloalkyl, —O—(C1-C6 alkyl), —O—(C1-C6 haloalkyl), —S(O)2—(C1-C6 alkyl), —C(O)O—(C1-C6 alkyl), C1-C6 hydroxyalkyl and —CN; R4a is selected from H, C1-C6 alkyl, 3 to 7-membered cycloalkyl, phenyl and 5 or 6-membered monocyclic heteroaryl, wherein said 3 to 7-membered cycloalkyl group, said phenyl group and said 5 or 6-membered monocyclic heteroaryl group can be optionally substituted with up to 2 groups, which can be the same or different, and are selected from C1-C6 alkyl, C1-C6 haloalkyl, halo, —CN, —O—(C1-C6 alkyl) and —O—(C1-C6 haloalkyl); each occurrence of R4b is independently selected from H, C1-C6 alkyl, 3 to 7-membered cycloalkyl, phenyl and 5 or 6-membered monocyclic heteroaryl, wherein said 3 to 7-membered cycloalkyl group, said phenyl group and said 5 or 6-membered monocyclic heteroaryl group can be optionally substituted with up to 2 groups, which can be the same or different, and are selected from C1-C6 alkyl, C1-C6 haloalkyl, halo, —CN, —O—(C1-C6 alkyl) and —O—(C1-C6 haloalkyl); each occurrence of R5 is independently selected from H, C1-C6 alkyl, C1-C6 hydroxyalkyl, —C(O)O—(C1-C6 alkyl), —(C1-C6 alkylene)r-phenyl, —(C1-C6 alkylene)r-(3 to 7-membered monocyclic cycloalkyl), —(C1-C6 alkylene)r-(4 to 7-membered monocyclic heterocycloalkyl), —(C1-C6 alkylene)r-(5 or 6-membered monocyclic heteroaryl) and —(C1-C6 alkylene)r-(9 or 10-membered bicyclic heteroaryl), wherein said phenyl group, said 3 to 7-membered monocyclic cycloalkyl group, said 4 to 7-membered monocyclic heterocycloalkyl group, said 5 or 6-membered monocyclic heteroaryl group and said 9 or 10-membered bicyclic heteroaryl group can be optionally substituted with up to 3 groups, which can be the same or different, and are selected from halo, C1-C6 alkyl, C1-C6 haloalkyl, phenyl, 3 to 7-membered monocyclic cycloalkyl, —O—(C1-C6 alkyl), —O—(C1-C6 haloalkyl), —S(O)2—C1-C6 alkyl, —C(O)O—(C1-C6 alkyl), C1-C6 hydroxyalkyl and —CN; R6 and R7 are each independently selected from hydrogen, C1-C6 alkyl, phenyl, 3 to 7-membered monocyclic cycloalkyl, 3 to 7-membered monocyclic heterocycloalkyl and 5 or 6-membered monocyclic heteroaryl; and R8 is selected from H, C1-C6 alkyl and 3 to 7-membered monocyclic cycloalkyl; R9 is selected from H, C1-C6 alkyl, C1-C6 haloalkyl, phenyl, 3 to 7-membered monocyclic cycloalkyl, 3 to 7-membered monocyclic heterocycloalkyl and 5 or 6-membered monocyclic heteroaryl; each occurrence of R10 is independently selected from H, halo, C1-C6 alkyl, C1-C6 haloalkyl, —O—(C1-C6 alkyl), —O—(C1-C6 haloalkyl) and —CN; each occurrence of n is independently 1 or 2; and each occurrence of r is independently 0 or 1.
地址 Phoenixville PA US